>APPENDIX 3: ORAL PREPARATIONS FOR TREATMENT OF IRON DEFICIENCY ANAEMIA (IDA) IN AUSTRALIA* NAME TABLET ELEMENTAL FORMULATION (Manufacturer) IRON CONTENT FERRO-LIQUID Ferrous Sulphate 30 mg/5 mL (AFT pharmaceuticals) Oral solution PBS listed FEFOL® Iron and folate Ferrous Sulphate 270 mg 87.4 mg supplement Folic acid 300 mcg (Pharm-a-care) Delayed release capsule Ferrous Fumarate 310 mg 100 mg (AFT pharmaceuticals) Folic acid 350 mcg Ferro-tab Ferrous Fumarate 200mg 65.7 mg (AFT pharmaceuticals) FERRO-GRADUMET Ferrous Sulphate 325 mg 105 mg (Abbott) Modified release tablet FERRO-GRAD C Ferrous Sulphate 325 mg 105 mg (Abbott) Ascorbic acid 500 mg Modified release tablet 250 mg FGF Ferrous Sulphate 80 mg (Abbott) Modified release tablet #Maltofer Iron polymaltose 370 mg 100 mg (Aspen Pharmacare)
>APPENDIX 3: ORAL PREPARATIONS FOR TREATMENT OF IRON DEFICIENCY ANAEMIA (IDA) IN AUSTRALIA* NAME (Manufacturer) TABLET FORMULATION ELEMENTAL IRON CONTENT FERRO-LIQUID (AFT pharmaceuticals) PBS listed Ferrous Sulphate Oral solution 30 mg/5 mL FEFOL® Iron and folate supplement (Pharm-a-care) Ferrous Sulphate 270 mg Folic acid 300 mcg Delayed release capsule 87.4 mg (AFT pharmaceuticals) Ferrous Fumarate 310 mg Folic acid 350 mcg 100 mg Ferro-tab (AFT pharmaceuticals) Ferrous Fumarate 200mg 65.7 mg FERRO-GRADUMET (Abbott) Ferrous Sulphate 325 mg Modified release tablet 105 mg FERRO-GRAD C (Abbott) Ferrous Sulphate 325 mg Ascorbic acid 500 mg Modified release tablet 105 mg FGF (Abbott) 250 mg Ferrous Sulphate Modified release tablet 80 mg #Maltofer (Aspen Pharmacare) Iron polymaltose 370 mg 100 mg
appendix-3-iron-product-choice-and-dose-calculation-adults20052016.docx